FindTrial
Sign In

The efficacy of different skull bore hole sites on the prognosis of chronic subdural hematomas: A randomized controlled trial

The efficacy of different skull bore hole sites on the prognosis of chronic subdural hematomas: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033967
Enrollment
Unknown
Registered
2020-06-19
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic subdural hematomas

Interventions

2:via frontal bone bore hole group
1:via parietal bone bore hole

Sponsors

The Second Affiliated Hospital of Nanhua University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with unilateral or bilateral chronic subdural hematoma requiring surgical treatment; 2. Patients who understand and agree with the study.

Exclusion criteria

Exclusion criteria: 1. Patients with critical illness and unstable vital signs; 2. Patients with CSDH caused by tumor, blood disease and other reasons; 3. Patients with abnormal liver function or severe liver disease; 4. Patients with poor cardiopulmonary function or coagulation dysfunction.

Design outcomes

Primary

MeasureTime frame
Hematoma residual volume and ratio;Gas volume in hematoma cavity;recurrent;Modified Markwalder score;mRS score;—

Countries

China

Contacts

Public ContactBing Wang

The Second Affiliated Hospital of Nanhua University

xjtubw@163.com+86 15273435847

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026